Clare L Murphy
@clarelmurphy.bsky.social
Consultant Cardiologist with specialist interest in Heart Failure, NHS Forth Valley.
Immediate past National Clinical Lead for Heart Failure 🏴
Views my own.
Immediate past National Clinical Lead for Heart Failure 🏴
Views my own.
Reposted by Clare L Murphy
📢 Scotland launches its first Specialist Nursing in #Cardiology Framework, setting national standards for cardiology nurse specialists. A significant step towards consistent, high-quality cardiac care across the country
Read more: snapca.co.uk/news/f/new-f...
#Cardiology #CNSvalue #CardioSky
Read more: snapca.co.uk/news/f/new-f...
#Cardiology #CNSvalue #CardioSky
New framework sets standard for Cardiology Nurse Specialists
Today marks an important milestone with the launch of Scotland’s first national framework for Specialist Nursing in Cardiology. Unveiled at Forth Valley Royal Hospital, the Framework aims to standardi...
snapca.co.uk
May 13, 2025 at 8:57 PM
📢 Scotland launches its first Specialist Nursing in #Cardiology Framework, setting national standards for cardiology nurse specialists. A significant step towards consistent, high-quality cardiac care across the country
Read more: snapca.co.uk/news/f/new-f...
#Cardiology #CNSvalue #CardioSky
Read more: snapca.co.uk/news/f/new-f...
#Cardiology #CNSvalue #CardioSky
Reposted by Clare L Murphy
CLEAR trial: Should we routinely use Spironolactone after Acute Myocardial Infarction?
No!
#AHA2024
www.nejm.org/doi/full/10....
No!
#AHA2024
www.nejm.org/doi/full/10....
Routine Spironolactone in Acute Myocardial Infarction | NEJM
Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial...
www.nejm.org
November 17, 2024 at 4:19 PM
CLEAR trial: Should we routinely use Spironolactone after Acute Myocardial Infarction?
No!
#AHA2024
www.nejm.org/doi/full/10....
No!
#AHA2024
www.nejm.org/doi/full/10....
Reposted by Clare L Murphy
CLEAR trial (Part 2): Should we routinely use Colchicine after acute myocardial infarction?
Also no!
#AHA2024
www.nejm.org/doi/full/10....
Also no!
#AHA2024
www.nejm.org/doi/full/10....
Colchicine in Acute Myocardial Infarction | NEJM
Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 fac...
www.nejm.org
November 17, 2024 at 4:25 PM
CLEAR trial (Part 2): Should we routinely use Colchicine after acute myocardial infarction?
Also no!
#AHA2024
www.nejm.org/doi/full/10....
Also no!
#AHA2024
www.nejm.org/doi/full/10....
Reposted by Clare L Murphy
Correct link: jamanetwork.com/journals/jam...
Partial Cardiac Denervation to Prevent Postoperative Atrial Fibrillation After CABG
This randomized clinical trial examines whether a partial cardiac denervation procedure reduces the incidence of postoperative atrial fibrillation among patients undergoing isolated coronary artery by...
jamanetwork.com
November 17, 2024 at 3:54 PM
Correct link: jamanetwork.com/journals/jam...
Reposted by Clare L Murphy
Reposted by Clare L Murphy
VANISH2: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
#AHA2024
www.nejm.org/doi/full/10....
#AHA2024
www.nejm.org/doi/full/10....
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia | NEJM
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tac...
www.nejm.org
November 17, 2024 at 4:29 PM
VANISH2: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
#AHA2024
www.nejm.org/doi/full/10....
#AHA2024
www.nejm.org/doi/full/10....
Reposted by Clare L Murphy
#LBCT #SUMMIT trial #AHA24
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
November 16, 2024 at 3:16 PM
#LBCT #SUMMIT trial #AHA24
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
Reposted by Clare L Murphy
Invited Commentary on the FINEARTS-HF trial:
The Fine Art and Science of Translating Trials Results Into Clinical Practice
#AHA24
Read it now in JAMA Cardiology: https://ja.ma/4ex15bP
The Fine Art and Science of Translating Trials Results Into Clinical Practice
#AHA24
Read it now in JAMA Cardiology: https://ja.ma/4ex15bP
November 17, 2024 at 2:57 PM
Invited Commentary on the FINEARTS-HF trial:
The Fine Art and Science of Translating Trials Results Into Clinical Practice
#AHA24
Read it now in JAMA Cardiology: https://ja.ma/4ex15bP
The Fine Art and Science of Translating Trials Results Into Clinical Practice
#AHA24
Read it now in JAMA Cardiology: https://ja.ma/4ex15bP
Reposted by Clare L Murphy
Among patients with ischemic cardiomyopathy & VT an initial strategy of catheter ablation ⚡️led to a lower risk of a composite primary end-point event 🆚 antiarrhythmic drug therapy 💊
#AHA24 #VANISH2 #LBCT
📎 www.nejm.org/doi/full/10....
#AHA24 #VANISH2 #LBCT
📎 www.nejm.org/doi/full/10....
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia | NEJM
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tac...
www.nejm.org
November 17, 2024 at 4:09 AM
Among patients with ischemic cardiomyopathy & VT an initial strategy of catheter ablation ⚡️led to a lower risk of a composite primary end-point event 🆚 antiarrhythmic drug therapy 💊
#AHA24 #VANISH2 #LBCT
📎 www.nejm.org/doi/full/10....
#AHA24 #VANISH2 #LBCT
📎 www.nejm.org/doi/full/10....